IL-6 anticorps

N° du produit ABIN2191746

Cet anticorps anti-IL-6 est un anticorps Rat Monoclonal détectant IL-6 dans IA, D et InhA. Adapté pour Souris. Ce Primary Antibody a été cité dans 4+ publications.

Aperçu rapide pour IL-6 anticorps (ABIN2191746)

Antigène: IL-6 (IL6) (Interleukin 6 (IL6))

Reactivité: Souris

Hôte: Rat

Clonalité: Monoclonal

Conjugué: Cet anticorp IL-6 est non-conjugé

Application: Immunoassay (IA), Detection (D), Inhibition Assay (InhA)

Clone: MP5-20F3

Détail du produit anti-IL-6 anticorps

Stérilité: 0.2 μm filtered

Information d'application

Indications d'application: For neutralisation of biological activity dilutions have to be made according to the amount of IL-6 to be inactivated.

Restrictions: For Research Use only

Stockage

Buffer: PBS containing 0.1 % bovine serum albumin.

Stock: 4 °C

Stockage commentaire: Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.

Date de péremption: 12 months

Références pour anticorps anti-IL-6 (ABIN2191746)

Hirano: "Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias." dans: International journal of cell cloning, Vol. 9, Issue 3, pp. 166-84, (1991) (PubMed).

Hooghe-Peters, Velkeniers, Vanhaelst, Hooghe: "Interleukin-1, interleukin-6: messengers in the neuroendocrine immune system?" dans: Pathology, research and practice, Vol. 187, Issue 5, pp. 622-5, (1991) (PubMed).

Takatsuki, Okano, Suzuki, Chieda, Takahara, Hirano, Kishimoto, Hamuro, Akiyama: "Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 141, Issue 9, pp. 3072-7, (1988) (PubMed).

McKenzie: "Alloantigen presentation by B cells. Requirement for IL-1 and IL-6." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 141, Issue 9, pp. 2907-11, (1988) (PubMed).

Détails sur IL-6

Antigène: IL-6 (IL6) (Interleukin 6 (IL6))

Autre désignation: Interleukin 6

Sujet: The antibody neutralizes mouse interleukin 6 (IL-6). It does not cross-react with LPS (the component of the bacterial cell wall which is considered responsible for the toxicity of gram-negative bacteria) and TNF- alpha nor does it bind to either human or rat IL-6. The antibody inhibits IL-6 induced proliferation of the B9 assay. IL-6 is a pluripotent 20-22 kDa cytokine which plays a role in the pathophysiology of severe infection and regulates the immune response, acute phase reaction and haematopoiesis. IL-6 plays a critical role in B-cell differentiation to plasma cells and is a potent growth factor for plasmacytoma and myeloma. Continuous IL-6 gene expression makes an essential contribution to a multistep oncogenesis of plasma cell neoplasia. IL-6 is a very useful culture supplement for the generation of a high number of antibody-producing hybridomas.

Pathways: Signalisation TLR, Hormone Transport, Negative Regulation of Hormone Secretion, Myometrial Relaxation and Contraction, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Regulation of Carbohydrate Metabolic Process, Autophagy, Cell RedoxHomeostasis, Cancer Immune Checkpoints, Inflammasome